References

  1. International Standards for Tuberculosis Care. The Hague: Tuberculosis Coalition for Technical Assistance; 2014.
  2. Health systems strengthening glossary [website]. Geneva: World Health Organization; 2016.
  3. A people-centred model of TB care. A blueprint for eastern European and central Asian countries, first edition. Copenhagen: World Health Organization Regional Office for Europe; 2017 (https://www.euro.who.int/__data/assets/pdf_file/0004/342373/TB_Content_WHO_PRO_eng_final.pdf, accessed 22 June 2022).
  4. Horter S, Daftary A, Keam T, Bernays S, Bhanushali K, Chavan D et al. Person-centred care in TB. Int J Tuberc Lung Dis. 2021;25(10):784–7 (http://www.ncbi.nlm.nih.gov/pubmed/34615573, accessed 18 June 2022).
  5. End TB Strategy. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization; 2014 (https://www.who.int/publications/i/item/WHO-HTM-TB-2015.19, accessed 23 June 2022).
  6. Moving to people-centred care: achieving better TB outcomes. TB Europe Coalition. 2017 (https://www.tbcoalition.eu/wp-content/uploads/2020/02/Moving-to-People-centred-Care-Achieving-Better-TB-Outcomes.pdf, accessed 18 June 2022). 
  7. Ethics guidance for the implementation of the End TB strategy. Geneva, Switzerland, World Health Organization. 2017 (https://apps.who.int/iris/handle/10665/254820, accessed 18 June 2022).
  8. Sah S. Craig G, Mandelbaum M. Psychosocial counselling and treatment adherence support for people with tuberculosis. Paric: International Union Against Tuberculosis and Lung Disease; 2021 (https://theunion.org/sites/default/files/2021–04/TheUnion_TBAlert_PsychosocialCounselling_April2021_webversion.pdf, accessed 18 June 2022).
  9. Declaration of the Rights of People affected by TB. Geneva: Stop TB Parnership; 2019 (https://stoptb.org/assets/documents/communities/FINAL%20Declaration%20on%20the%20Right%20of%20People%20Affected%20by%20TB%2013.05.2019.pdf, accessed 18 June 2022).
  10. The Patients’ Charter for Tuberculosis Care. San Francisco (CA): World Care Council; 2006.
  11. Companion handbook to the WHO guidelines for the programmatic management of drugresistant tuberculosis. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/bitstream/handle/10665/130918/9789241548809_eng.pdf, accessed 18 June 2022).
  12. A patient-centred approach to TB care. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/bitstream/handle/10665/272467/WHO-CDS-TB-2018.13-eng.pdf, accessed 18 June 2022).
  13. Implementing the end TB strategy: the essentials. Geneva: World Health Organization; 2015 (https://www.who.int/publications/i/item/9789241509930, accessed 18 June 2022).
  14. Best practice for the care of patients with tuberculosis: a guide for low-income countries. Paris: International Union Against Tuberculosis and Lung Disease; 2017 (https://theunion.org/technical-publications/best-practice-for-the-care-of-patients-with-tuberculosis-a-guide-for-low-income-countries, accessed 18 June 2022). 
  15. Consolidated guidelines on tuberculosis. Module 4: Treatment. Tuberculosis care and support. Geneva: World Health Organization; 2022.
  16. Guidelines for treatment of drug-susceptible tuberculosis and patient care – 2017 update. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/handle/10665/255052, accessed 18 June 2022)
  17. Hayward SE, Deal A, Rustage K, Nellums LB, Sweetland AC, Boccia D et al. The relationship between mental health and risk of active tuberculosis: a systematic review. BMJ Open. 2022;12(1). doi: (12(1):e048945).
  18. Li H, Ji Y, Chen T. The roles of different sources of social support on emotional well-being among Chinese elderly. PloS one. 2014;9(3):e90051-e (https://pubmed.ncbi.nlm.nih.gov/24594546, accessed 18 June 2022).
  19. Standardized package of community-based support services to improve TB outcomes. Copenhagen: World Health Organization Regional Office for Europe & TB Europe Coalition; 2021 (https://www.tbcoalition.eu/wp-content/uploads/2021/10/Standardized-package-of-community-based-supportive-services-to-improve-TB-outcomes-27_Oct_21.pdf, accessed 18 June 2022).
  20. United To End TB. Every word counts: suggested language and usage for tuberculosis communication. First edition. Geneva, Stop TB Partnership. 2013 (https://stoptb.org/assets/documents/resources/publications/acsm/LanguageGuide_ForWeb20131110.pdf, accessed 18 June 2022).
  21. Guideline: nutritional care and support for patients with tuberculosis. Geneva: World Health Organization; 2013 (https://apps.who.int/iris/handle/10665/94836, accessed 18 June 2022).
  22. WHO framework for collaborative action on tuberculosis and comorbidities. Geneva: World Health Organization; 2022.
  23. Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595 (http://www.ncbi.nlm.nih.gov/pubmed/29969463, accessed 18 June 2022).
  24. Digital health for the End TB Strategy: an agenda for action. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/handle/10665/205222, accessed 18 June 2022).
  25. Handbook for the use of digital technologies to support tuberculosis medication adherence. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/handle/10665/259832, accessed 18 June 2022).
  26. Ngwatu BK, Nsengiyumva NP, Oxlade O, Mappin-Kasirer B, Nguyen NL, Jaramillo E et al. The impact of digital health technologies on tuberculosis treatment: a systematic review. Eur Respir J. 2018;51(1):1701596. doi: 10.1183/13993003.01596–2017.
  27. Nsengiyumva NP, Mappin-Kasirer B, Oxlade O, Bastos M, Trajman A, Falzon D et al. Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support. Eur Respir J. 2018;52(5):1801363. doi:10.1183/13993003.01363–2018.
  28. Liu XQ, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng GL et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PloS Med. 2015;12(9):e1001876.
  29. 99DOTS [website] (https://www.99dots.org/, accessed 18 June 2022).
  30. Cattamanchi A, Crowder R, Kityamuwesi A, Kiwanuka N, Lamunu M, Namale C et al. Digital adherence technology for tuberculosis treatment supervision: a stepped-wedge cluster-randomized trial in Uganda. PloS Med. 2021;18(5): e1003628.
  31. Thomas BE, Kumar JV, Chiranjeevi M, Shah D, Khandewale A, Thiruvengadam K et al. Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications: comparison of digital adherence data with urine Isoniazid testing. Clin Infect Dis. 2020;71(9):e513–6.
  32. Chuck C, Robinson E, Macaraig M, Alexander M, Burzynski J. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City. Int J Tuberc Lung Dis. 2016;20(5):588–93. doi:10.5588/ijtld.15.0738.
  33. Wade VA, Karnon J, Eliott JA, Hiller JE. Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation. PLoS One. 2012;7(11):e50155 (http://www.ncbi.nlm.nih.gov/pubmed/23226243, accessed 18 June 2022).
  34. Story A, Aldridge RW, Smith CM, Garber E, Hall J, Ferenando G et al. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial. Lancet. 2019;393(10177):1216–24 http://www.ncbi.nlm.nih.gov/pubmed/30799062, accessed 18 June 2022).
  35.  Ravenscroft L, Kettle S, Persian R, Ruda S, Severin L, Doltu S et al. Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova. Eur Respir J. 2020;56(2):2000493 (http://www.ncbi.nlm.nih.gov/pubmed/32381495, accessed 18 June 2022).
  36. Dick J, Lombard C. Shared vision--a health education project designed to enhance adherence to anti-tuberculosis treatment. Int J Tuberc Lung Dis. 1997;1(2):181–6 (http://www.ncbi.nlm.nih.gov/pubmed/9441085, accessed 18 June 2022).
  37. Clark PM, Karagoz T, Apikoglu-Rabus S, Izzettin FV. Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm. 2007;64(5):497–505 (http://www.ncbi.nlm.nih.gov/pubmed/17322163, accessed 18 June 2022).
  38. Datiko DG, Lindtjorn B. Health extension workers improve tuberculosis case detection and treatment success in southern Ethiopia: a community randomized trial. PLoS One. 2009;4(5):e5443 (http://www.ncbi.nlm.nih.gov/pubmed/19424460, accessed 18 June 2022).
  39. Kigozi NG, Heunis JC, Engelbrecht MC, Janse van Rensburg AP, van Rensburg HCJD. Tuberculosis knowledge, attitudes and practices of patients at primary health care facilities in a South African metropolitan: research towards improved health education. BMC public health. 2017;17(1):795- (https://pubmed.ncbi.nlm.nih.gov/29017526, accessed 18 June 2022).
  40. Idris NA, Zakaria R, Muhamad R, Nik Husain NR, Ishak A, Wan Mohammad WMZ. The effectiveness of tuberculosis education programme in Kelantan, Malaysia on knowledge, attitude, practice and stigma towards tuberculosis among adolescents. Malays J Med Sci. 2020;27(6):102–14.
  41. Yousif K, Ei Maki M, Babikir RK, Abuaisha H. The effect of an educational intervention on awareness of various aspects of pulmonary tuberculosis in patients with the disease. East Mediterr Health J. 2021;27(3):287–92.
  42. Koech BA, Nyamgoba EN. The role of communication in the management of tuberculosis disease. IOSR Journal of Humanities and Social Science. 2017;22(5):62–6.
  43. Lief H, Fox R. Training for “detached concern” in medical students. In: Lief H, editor. The psychological basis of medical practice. New York (NY): Harper & Row; 1963:12–35.
  44. Zachariah R, Harries AD, Srinath S, Ram S, Viney K, Singogo E et al. Language in tuberculosis services: can we change to patient-centred terminology and stop the paradigm of blaming the patients? Int J Tuberc Lung Dis. 2012;16(6):714–7 (https://www.ncbi.nlm.nih.gov/pubmed/22613683, accessed 18 June 2022).
  45. mhGAP Intervention Guide – Version 2.0. Geneva, World Health Organization 2019 (https://www.who.int/publications/i/item/9789241549790, accessed 18 June 2022).
  46. Nursing guide for managing side effects to drug-resistant TB treatment. Geneva: International Council of Nurses and Curry International Tuberculosis Center; 2018 (https://www.icn.ch/system/files/documents/2020–11/CITC_NursingGuide_English_v14_WEB_pages.pdf, accessed 18 June 2022).
  47. Njie GJ, Khan A. Prevalence of tuberculosis and mental disorders comorbidity: a systematic review and meta-analysis. J Immigr Minor Health. 2021 (https://www.ncbi.nlm.nih.gov/pubmed/34796457, accessed 18 June 2022).
  48. de Araujo GS, Pereira SM, dos Santos DN, Marinho JM, Rodrigues LC, Barreto ML. Common mental disorders associated with tuberculosis: a matched case-control study. PLoS One. 2014;9(6):e99551 (https://www.ncbi.nlm.nih.gov/pubmed/24937319, accessed 18 June 2022).
  49. Harling G, Castro MC. A spatial analysis of social and economic determinants of tuberculosis in Brazil. Health Place. 2014;25:56–67 (https://www.ncbi.nlm.nih.gov/pubmed/24269879, accessed 18 June 2022).
  50. Fonseca M, Guimarães M, Vasconcelos E. Sofrimento difuso e transtornos mentais comuns: uma revisão bibliográfica. (Diffuse distress and common mental disorders: a bibliographic review). Rev. APS. 2008;11(3):285–94.
  51. Janse Van Rensburg A, Dube A, Curran R, Ambaw F, Murdoch J, Bachmann M et al. Comorbidities between tuberculosis and common mental disorders: a scoping review of epidemiological patterns and person-centred care interventions from low-to-middle income and BRICS countries. Infect Dis Poverty. 2020;9(1):4 (https://www.ncbi.nlm.nih.gov/pubmed/31941551, accessed 18 June 2022).
  52. Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberc Res Treat. 2013;2013:489865 (https://www.ncbi.nlm.nih.gov/pubmed/23691305, accessed 18 June 2022).
  53. Wai PP, Shewade HD, Kyaw NTT, Thein S, Si Thu A, Kyaw KWY et al. Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar. PLoS One. 2018;13(3):e0194087 (https://www.ncbi.nlm.nih.gov/pubmed/29596434, accessed 18 June 2022).
  54. World Health Organization (WHO). Doing what matters in times of stress. An illustrated guide [website]. Geneva: World Health Organization (WHO); 2020 (https://www.who.int/publications/i/item/9789240003927, accessed 18 June 2022).
  55. World Health Organization (WHO). Problem management plus (PM+): individual psychological help for adults impaired by distress in communities exposed to adversity [website]. Geneva: World Health Organization 2016 (https://www.who.int/publications/i/item/WHO-MSD-MER-16.2, accessed 18 June 2022).
  56. Kübler-Ross E. On death and dying. London: Routledge; 1969.
  57. Block SD. Psychological issues in end-of-life care. J Palliat Med. 2006;9(3):751–72.
  58. Simon NM. Treating complicated grief. JAMA. 2013;310(4):416–23 (https://pubmed.ncbi.nlm.nih.gov/23917292, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530627, both accessed 18 June 2022).
  59. Hudson P, Remedios C, Zordan R, Thomas K, Clifton D, Crewdson M et al. Guidelines for the psychosocial and bereavement support of family caregivers of palliative care patients. J Palliat Med. 2012;15(6):696–702.
  60. Rapid communication: key changes to the treatment of drug-resistant tuberculosis. Information note. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/WHO-UCN-TB-2022–2, accessed 18 June 2022).
  61. WHO consolidated guidelines on tuberculosis. Module 4: Treatment – drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240007048, accessed 18 June 2022). 
  62. WHO operational handbook on tuberculosis. Module 4: Treatment – drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240006997, accessed 18 June 2022).
  63. WHO consolidated guidelines on tuberculosis, Module 4: Treatment – drug-susceptible tuberculosis treatment. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240048126, accessed 18 June 2022).
  64. Ho J, Byrne AL, Linh NN, Jaramillo E, Fox GJ. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bulletin of the World Health Organization. 2017;95(8):584–93 (https://pubmed.ncbi.nlm.nih.gov/28804170, accessed 18 June 2022).
  65. TB Care II. Community-based care for drug-resistant tuberculosis: a guide for implementers [website]. North Carolina: USAID; 2017 (https://www.tbdiah.org/resources/publications/community-based-care-for-drug-resistant-tuberculosis-a-guide-for-implementers/, accessed 18 June 2022).
  66. Bhargava A, Bhargava M. Tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key. J Clin Tuberc Other Mycobact Dis. 2020;19:100155.
  67. Roadmap towards ending TB in children and adolescents. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/275422, accessed 18 June 2022).
  68. Graham SM, Sekadde MP. Case detection and diagnosis of tuberculosis in primary-care settings. Paediatr Int Child Health. 2019;39(2):84–7 (http://www.ncbi.nlm.nih.gov/pubmed/30957711, accessed 18 June 2022).
  69. WHO operational handbook on tuberculosis. Module 5: Management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240046832, accessed 18 June 2022).
  70. WHO consolidated guidelines on tuberculosis. Module 5: Management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240046764, accessed 18 June 2022).
  71. The Sustainable Development Agenda [website]. New York (NY): United Nations; 2021 (https://www.un.org/sustainabledevelopment/development-agenda/, accessed 18 June 2022). 
  72. Talukder K, Salim MAH, Jerin I, Sharmin F, Talukder MQK, Marais BJ et al. Intervention to increase detection of childhood tuberculosis in Bangladesh. Int J Tuberc Lung Dis. 2012;16(1):70–5. doi: 10.5588/ijtld.11.0060.
  73. Ketema L, Dememew ZG, Assefa D, Gudina T, Kassa A, Letta T et al. Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: a mixed method study. PloS One. 2020;15(11):e0241977.
  74. Dongo JP, Graham SM, Nsonga J, Wabwire-Mangen F, Maleche-Obimbo E, Mupere E et al. Implementation of an effective decentralised programme for detection, treatment and prevention of tuberculosis in children. Trop Med Infect Dis. 2021;6(3):131.
  75. Maha A, Majumdar SS, Main S, Phillip W, Witari K, Schulz J et al. The effects of decentralisation of tuberculosis services in the East New Britain Province, Papua New Guinea. Public Health Action. 2019;9:S43–9.
  76. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization; 2012 (https://apps.who.int/iris/handle/10665/44789, accessed 18 June 2022).
  77. Standards for improving the quality of care for children and young adolescents in health facilities. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/272346, accessed 18 June 2022).
  78. Young M, Wolffieim C, Marsh DR, Hammamy D. World Health Organization/United Nations Children’s Fund Joint Statement on Integrated Community Case Management: An equity-focused trategy to improve access to essential treatment services for children. Am J Trop Med Hyg. 2012;87(5):6–10.
  79. Integrated Management of Childhood Illness: chart booklet. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/104772, accessed 18 June 2022).
  80. Marais BJ, Obihara CC, Warren RM, Schaaf HS, Gie RP, Donald PR. The burden of childhood tuberculosis:a public health perspective. Int J Tuberc Lung Dis. 2005;9(12):1305–13 (http://www.ncbi.nlm.nih.gov/pubmed/16466051, accessed 18 June 2022).
  81. Onazi O, Gidado M, Onazi M, Daniel O, Kuye J, Obasanya O et al. Estimating the cost of TB and its social impact on TB patients and their households. Public Health Action. 2015;5(2):127–31 (http://www.ncbi.nlm.nih.gov/pubmed/26400384, accessed 18 June 2022).
  82. Goyal-Honavar A, Markose AP, Chhakchhuakk L, John SM, Joy S, Kumar SD et al. Unmasking the human face of TB. The impact of tuberculosis on the families of patients. J Family Med Prim Care. 2020;9(10):5345–50.
  83. Foo C, Shrestha P, Wang L, Du Q, Garcia-Basteiro AL, Abdullah AS et al. Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): a systematic review. PLoS Med. 2022;19(1):e1003899 (http://www.ncbi.nlm.nih.gov/pubmed/35041654, accessed 18 June 2022).
  84. Legido-Quigley H, Montgomery CM, Khan P, Atun R, Fakoya A, Getahun H et al. Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health. 2013;18(2):199–211 (http://www.ncbi.nlm.nih.gov/pubmed/23217030, accessed 18 June 2022).
  85. China: multidisciplinary teams and integrated service delivery across levels of care. Country case studies on primary health care. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/326085, accessed 18 June 2022).
  86. Public–private mix for TB prevention and care: a roadmap. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/333885, accessed 18 June 2022).
  87. Stallworthy G, Dias HM, Pai M. Quality of tuberculosis care in the private health sector. J Clin Tuberc Other Mycobact Dis. 2020;20:100171 (https://www.ncbi.nlm.nih.gov/pubmed/32642560, accessed 18 June 2022).
  88. Uplekar M, Juvekar S, Morankar S, Rangan S, Nunn P. Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis. 1998;2(4):324–9 (https://www.ncbi.nlm.nih.gov/pubmed/9559404, accessed 18 June 2022).
  89. COVID-19 – considerations for tuberculosis (TB) care. Information note. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/341126, accessed 18 June 2022).
  90. Briefing note: testing for both tuberculosis and SARS-CoV-2. Geneva: Global Fund to Fight AIDS, Tuberculosis and Malaria; 2021 (https://www.theglobalfund.org/en/covid-19/news/2021–11–03-briefing-note-testingfor-both-tuberculosis-and-sars-cov-2/, accessed 18 June 2022).
  91. Krakauer EL, Dheda K, Kalsdorf B, Kuksa L, Nadkarni A, Nhung NV et al. Palliative care and symptom relief for people affected by multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2019;23(8):881–90 (https://www.ncbi.nlm.nih.gov/pubmed/31533877, accessed 18 June 2022).
  92. Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X et al. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2018;391(10128):1391–454 (https://www.ncbi.nlm.nih.gov/pubmed/29032993, accessed 18 June 2022).
  93. Beaumont A-L, Doumbia A, Chateau N, Meynard J-L, Pacanowski J, Valin N et al. Why are people still dying of drug-susceptible TB in Paris in the 21(st) century? Int J Tuberc Lung Dis. 2022;26(2):142–9 (https://www.ncbi.nlm.nih.gov/pubmed/35086626, accessed 18 June 2022).
  94. Resolution WHA67.19. Strengthening of palliative care as a component of comprehensive care throughout the life course. Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/162863, accessed 18 June 2022).
  95. Integrating palliative care and symptom relief into primary health care: a WHO guide for planners, implementers and managers. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/274559, accessed 18 June 2022).
  96. Resolution 69.24. Strengthening integrated, people-centred health services. World Health Assembly, Geneva Sixty-ninth World Health Assembly; Geneva, 23–28 May 2016. Geneva: World Health Organization; 2016 (https://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_R24-en.pdfhttps://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_R24-en.pdf, accessed 18 June 2022).
  97. Connor SR. Palliative care for tuberculosis. J Pain Symptom Manag. 2018;55(2):S178–80.
  98. Connor S, Foley K, Harding R, Jaramillo E. Declaration on palliative care and MDR/XDR-TB. Int J Tuberc Lung Dis. 2012;16(6):712–3. doi:10.5588/ijtld.12.0267.
  99. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269–78.
  100. Manji M, Shayo G, Mamuya S, Mpembeni R, Jusabani A, Mugusi F. Lung functions among patients with pulmonary tuberculosis in Dar es Salaam – a cross-sectional study. BMC Pulm Med. 2016;16(1):58.
  101. Maguire GP, Anstey NM, Ardian M, Waramori G, Tjitra E, Kenangalem E et al. Pulmonary tuberculosis, impaired lung function, disability and quality of life in a high-burden setting. Int J Tuberc Lung Dis. 2009;13(12):1500–6. 
  102. Vashakidze SA, Kempker JA, Jakobia NA, Gogishvili SG, Nikolaishvili KA, Goginashvili LM et al. Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis. Int J Infect Dis. 2019;82:66–72.
  103. Connor S, editor. Global atlas of palliative care, second edition. London: Worldwide Palliative Care Alliance; 2020.
  104. Planning and implementing palliative care services: a guide for programme managers. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/handle/10665/250584, accessed 18 June 2022).
  105. Krakauer EL, Kwete X, Verguet S, Arreola-Ornelas H, Bhadelia A, Mendez O et al. Palliative care and pain control. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CD et al., editors. Disease control priorities: improving health and reducing poverty, Washington (DC); The World Bank; 2017 (http://www.ncbi.nlm.nih.gov/pubmed/30212149, accessed 18 June 2022).
  106. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939–44 (https://www.ncbi.nlm.nih.gov/pubmed/12403875, accessed 18 June 2022).
  107. Bausewein C, Currow D, Johnson M, editors. Palliative care in respiratory disease. Sheffield: European Respiratory Society; 2016.
  108. Fine RL. Ethical and practical issues with opioids in life-limiting illness. Proc (Bayl Univ Med Cent). 2007;20(1):5–12 (https://www.ncbi.nlm.nih.gov/pubmed/17256034, accessed 18 June 2022).
  109. Mahler DA, Selecky PA, Harrod CG, Benditt JO, Carrieri-Kohlman V, Curtis JR et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010;137(3):674–91 (https://www.ncbi.nlm.nih.gov/pubmed/20202949, accessed 18 June 2022).
  110. Qaseem A, Snow V, Shekelle P, Casey DE Jr., Cross JT Jr., Owens DK et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148(2):141–6 (https://www.ncbi.nlm.nih.gov/pubmed/18195338, accessed 18 June 2022).
  111. Palliative care for the patient with incurable cancer or advanced disease, Part 2: Pain and symptom management – dyspnea. Guidelines & Protocols Advisory Committee. New Westminster: BC Centre for Palliative Care; 2017 (http://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/palliative2_dyspnea.pdf, accessed 18 June 2022).
  112. Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults. NICE clinical guideline 140. Manchester: National Collaborating Centre for Cancer; 2012 (www.nice.org.uk/nicemedia/live/13745/59287/59287.pdf, accessed 18 June 2022).
  113. Ragan EJ, Kleinman MB, Sweigart B, Gnatienko N, Parry CD, Horsburgh CR et al. The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2020;24(1):73–82 (https://www.ncbi.nlm.nih.gov/pubmed/32005309, accessed 18 June 2022).
  114. Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009;48(1):72–82 (https://www.ncbi.nlm.nih.gov/pubmed/19046064, accessed 18 June 2022).
  115. Getahun H, Gunneberg C, Sculier D, Verster A, Raviglione M. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. Curr Opin HIV AIDS. 2012;7(4):345–53 (https://www.ncbi.nlm.nih.gov/pubmed/22678489, accessed 18 June 2022)
  116. Shin S, Livchits V, Connery HS, Shields A, Yanov S, Yanova G et al. Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia. Addiction. 2013;108(8):1387–96 (https://www.ncbi.nlm.nih.gov/pubmed/23490304, accessed 18 June 2022).
  117. Bruce RD, Lambdin B, Chang O, Masao F, Mbwambo J, Mteza I et al. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. Int J Drug Policy. 2014;25(1):22–5 (https://www.ncbi.nlm.nih.gov/pubmed/24210295, accessed 18 June 2022).
  118. Nadkarni A, Weiss HA, Weobong B, McDaid D, Singla DR, Park AL et al. Sustained effectiveness and cost-effectiveness of Counselling for Alcohol Problems, a brief psychological treatment for harmful drinking in men, delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trial. PLoS Med. 2017;14(9):e1002386 (https://www.ncbi.nlm.nih.gov/pubmed/28898239, accessed 18 June 2022).
  119. Nadkarni A, Weobong B, Weiss HA, McCambridge J, Bhat B, Katti B et al. Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial. Lancet. 2017;389(10065):186–95 (https://www.ncbi.nlm.nih.gov/pubmed/27988144, accessed 18 June 2022).
  120. Sharkey L, Loring B, Cowan M, Riley L, Krakauer EL. National palliative care capacities around the world: results from the World Health Organization Noncommunicable Disease Country Capacity Survey. Palliat Med. 2018;32(1):106–13 (https://www.ncbi.nlm.nih.gov/pubmed/28677988, accessed 18 June 2022).
  121. Assessing the development of palliative care worldwide: a set of actionable indicators. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/345532, accessed 18 June 2022).
  122. Davis MP, Temel JS, Balboni T, Glare P. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med. 2015;4(3):99–121 (https://www.ncbi.nlm.nih.gov/pubmed/26231807, accessed 18 June 2022).
  123. Desrosiers T, Cupido C, Pitout E, van Niekerk L, Badri M, Gwyther L et al. A hospital-based palliative care service for patients with advanced organ failure in sub-Saharan Africa reduces admissions and increases home death rates. J Pain Symptom Manage. 2014;47(4):786–92 (https://www.ncbi.nlm.nih.gov/pubmed/23969328, accessed 18 June 2022).
  124. Hongoro C, Dinat N. A cost analysis of a hospital-based palliative care outreach program: implications for expanding public sector palliative care in South Africa. J Pain Symptom Manage. 2011;41(6):1015–24 (https://www.ncbi.nlm.nih.gov/pubmed/21330096, accessed 18 June 2022).
  125. Mosoiu D, Dumitrescu M, Connor SR. Developing a costing framework for palliative care services. J Pain Symptom Manage. 2014;48(4):719–29 (https://www.ncbi.nlm.nih.gov/pubmed/24709365, accessed 18 June 2022.
  126. Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980–6 (https://www.ncbi.nlm.nih.gov/pubmed/26811521, accessed 18 June 2022).
  127. Postier A, Chrastek J, Nugent S, Osenga K, Friedrichsdorf SJ. Exposure to home-based pediatric palliative and hospice care and its impact on hospital and emergency care charges at a single institution. J Palliat Med. 2014;17(2):183–8 (https://www.ncbi.nlm.nih.gov/pubmed/24380448, accessed 18 June 2022).

Book navigation